Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Chopra, Yogi
CSIDE, NCT03619551: Conditioning SCID Infants Diagnosed Early	Recruiting	2	64	Canada, US	Busulfan, Cell processing for TCRαβ+/CD19+ depletion, CliniMACS	Michael Pulsipher, MD	SCID	08/26	08/26
NCT05426252: Thal-Fabs: Reduced Toxicity Conditioning for High Risk Thalassemia	Recruiting	1/2	20	Canada	Abatacept, Orencia, Sirolimus, Rapamicin	The Hospital for Sick Children, Thalassemia Foundation of Canada	Thalassemia in Children	12/25	12/26
NCT04937400: Delirium in Children Undergoing Stem Cell Transplantation	Active, not recruiting	N/A	1041	Canada, US	Daily screening for delirium, Cornell Assessment for Pediatric Delirium	Weill Medical College of Cornell University, National Cancer Institute (NCI)	Stem Cell Transplant Complications, Delirium	07/25	07/26